Our Pricing

Ozempic vs Mounjaro: Clinical Comparison for UK Patients

Published on: June 03, 2026

Choosing between ozempic vs mounjaro uk online requires understanding how these two leading weight loss injections differ in mechanism, efficacy, and tolerability. At Cured Pharmacy, both medications are in stock with transparent pricing from £135.00 UK prescriber assessment included, and same-day dispatch available for approved prescriptions.

Ozempic vs Mounjaro UK: How They Work Differently

Ozempic contains semaglutide, a GLP-1 receptor agonist that mimics one naturally occurring hormone to regulate appetite and blood sugar [1]. Mounjaro contains tirzepatide, the UK's first dual GIP/GLP-1 receptor agonist, activating two complementary pathways simultaneously [2]. This dual mechanism is why tirzepatide typically produces greater weight reduction in head-to-head comparisons.

Both medications slow gastric emptying, reduce hunger signals to the brain, and improve insulin sensitivity. The key difference lies in tirzepatide's additional GIP receptor activation, which enhances fat metabolism and may improve tolerability for some patients [2]. Clinical trials show this dual action translates to measurably different outcomes in real-world use.

Weight Loss Results: Mounjaro vs Ozempic Clinical Data

In the SURMOUNT-1 trial, patients taking the highest Mounjaro dose (15mg) achieved an average 22.5% total body weight reduction over 72 weeks [2]. By comparison, the STEP-1 trial showed semaglutide 2.4mg (marketed as Wegovy, the same active ingredient as Ozempic) produced an average 14.9% weight reduction over 68 weeks [3]. Both figures represent patients who completed the full trial period with lifestyle modifications.

Direct comparison trials are limited, but the SURPASS-2 study directly compared tirzepatide against semaglutide 1mg in patients with type 2 diabetes, showing superior weight loss with tirzepatide across all doses [4]. It's important to note that individual responses vary significantly—some patients respond exceptionally well to semaglutide-based treatments, whilst others achieve better results with tirzepatide.

Realistic Expectations for UK Patients

Your UK prescriber will emphasise that these medications work best alongside reduced calorie intake and increased physical activity. Trial participants received structured lifestyle support, and real-world results may differ. Most patients begin noticing appetite reduction within the first two weeks, with measurable weight changes typically appearing after 4-8 weeks of consistent use [1][2].

Side Effects: Ozempic vs Mounjaro Tolerability Profile

Both medications share similar gastrointestinal side effects—nausea, diarrhoea, constipation, and occasional vomiting are most common during dose escalation [1][2]. In clinical trials, approximately 44% of Mounjaro patients and 47% of Ozempic patients reported nausea, though severe cases leading to discontinuation remained under 7% for both treatments [2][3].

Interestingly, some prescribers observe that Mounjaro's dual mechanism may produce slightly better tolerability in patients who experienced significant nausea on semaglutide alone, though this remains anecdotal rather than definitively proven. Starting with the lowest dose and following the prescribed titration schedule significantly reduces side effect severity for both medications [1][2].

Managing Common Side Effects

Your UK clinical team will recommend eating smaller, more frequent meals, avoiding high-fat foods immediately after injection, and staying well-hydrated. Most gastrointestinal symptoms improve significantly after 4-8 weeks as your body adjusts to the medication. If side effects remain troublesome, your prescriber may adjust your titration schedule or consider switching between semaglutide and tirzepatide formulations [1].

Dosing and Administration: Practical Differences

Both Ozempic and Mounjaro are administered as once-weekly subcutaneous injections using pre-filled pens. Ozempic starts at 0.25mg weekly, increasing gradually to a maintenance dose of 1mg or 2mg depending on individual response and tolerability [1]. Mounjaro follows a similar escalation pattern, starting at 2.5mg and potentially increasing to 5mg, 7.5mg, 10mg, 12.5mg, or 15mg based on clinical assessment [2].

The injection technique is identical for both medications—patients inject into the abdomen, thigh, or upper arm, rotating sites weekly to prevent lipodystrophy. Each pen is single-use and requires refrigeration before first use, though can be kept at room temperature for up to 21 days once in use [1][2]. Your Cured Pharmacy dispense will include full administration instructions tailored to your prescribed medication.

Cost Comparison: Ozempic vs Mounjaro UK Pricing

At Cured Pharmacy, Mounjaro starts from £124.99 per pen, with final pricing dependent on your prescribed dose following clinical assessment. Transparent pricing is shown before you complete your consultation, with no hidden fees or subscription requirements. Both medications require ongoing treatment to maintain weight loss, and your UK prescriber will discuss realistic timeframes during your assessment.

Many patients ask whether the price difference reflects superior efficacy. Whilst tirzepatide demonstrates higher average weight loss in trials, individual response varies considerably—some patients achieve excellent results with lower-cost alternatives. Your prescriber will consider your medical history, previous treatment responses, budget considerations, and clinical goals when recommending the most appropriate option for your circumstances.

Insurance and NHS Availability

Currently, NHS prescription of weight loss medications remains limited to specialist services and patients meeting strict eligibility criteria. Most UK patients access these treatments through private prescriptions from registered online pharmacies like Cured Pharmacy. Private prescriptions are not typically covered by health insurance, though some policies may contribute—check your individual policy terms before purchasing.

Which Treatment Is Right for You? Clinical Considerations

Your UK prescriber will assess several factors when recommending between Ozempic and Mounjaro: your BMI and weight loss goals, any history of gastrointestinal conditions, previous responses to GLP-1 medications, concurrent medical conditions (particularly type 2 diabetes), and budget considerations. Patients with type 2 diabetes may benefit from either medication, as both improve glycaemic control alongside weight reduction [1][2].

If you've previously tried semaglutide-based treatments with limited success or significant side effects, switching to tirzepatide may offer improved outcomes. Conversely, if cost is a primary concern and your weight loss goals are moderate, semaglutide formulations may provide excellent value. There's no universally 'better' choice—the optimal treatment depends entirely on your individual clinical picture and personal circumstances.

At Cured Pharmacy, our UK-registered clinical team (led by Superintendent Pharmacist Tarun Kumar, GPhC 2233073) conducts thorough assessments to ensure you receive the most appropriate prescription. The consultation takes under three minutes to complete online, with prescriber review typically completed the same day for straightforward cases. Both Ozempic and Mounjaro are currently in stock with same-day dispatch available for approved prescriptions.

Scientific References

1. Wilding, J. P. H., Batterham, R. L., Calanna, S., et al. (2021). Once-Weekly Semaglutide in Adults with Overweight or Obesity. New England Journal of Medicine, 384(11), 989–1002. https://doi.org/10.1056/NEJMoa2032183 [accessed 13 August 2026]
2. Jastreboff, A. M., Aronne, L. J., Ahmad, N. N., et al. (2022). Tirzepatide Once Weekly for the Treatment of Obesity. New England Journal of Medicine, 387(3), 205–216. https://doi.org/10.1056/NEJMoa2206038 [accessed 13 August 2026]
3. Rubino, D., Abrahamsson, N., Davies, M., et al. (2021). Effect of Continued Weekly Subcutaneous Semaglutide vs Placebo on Weight Loss Maintenance in Adults With Overweight or Obesity: The STEP 4 Randomized Clinical Trial. JAMA, 325(14), 1414–1425. https://doi.org/10.1001/jama.2021.3224 [accessed 13 August 2026]
4. Frías, J. P., Davies, M. J., Rosenstock, J., et al. (2021). Tirzepatide versus Semaglutide Once Weekly in Patients with Type 2 Diabetes. New England Journal of Medicine, 385(6), 503–515. https://doi.org/10.1056/NEJMoa2107519 [accessed 13 August 2026]
5. NHS. (2026). Tirzepatide: a medicine to manage type 2 diabetes and treat obesity. https://www.nhs.uk/medicines/tirzepatide/ Accessed 13 August 2026.
6. NHS. (2026). Overweight and obesity in adults. https://www.nhs.uk/conditions/overweight-and-obesity/ Accessed 13 August 2026.
7. NHS England. (2026). Weight management injections. https://www.england.nhs.uk/ourwork/prevention/obesity/medicines-for-obesity/weight-management-injections/ Accessed 13 August 2026.

Information on this page is for educational purposes only and is not medical advice. All prescription treatments require clinical assessment by a UK-registered prescriber. Always consult a qualified healthcare professional before starting any new medication. Individual results may vary, and weight loss medications work best alongside reduced calorie intake and increased physical activity.